Omicron could replace Delta globally: Russian Gamaleya Institute chief

The Omicron strain of the coronavirus could eventually replace the Delta variant, as it is already happening in South Africa, Alexander Gintsburg said

omicron
ANI Asia
2 min read Last Updated : Dec 13 2021 | 11:32 AM IST

The Omicron strain of the coronavirus could eventually replace the Delta variant, as it is already happening in South Africa, Alexander Gintsburg, the director of Russia's Gamaleya Research Center for Epidemiology and Microbiology, told Sputnik.

"Reports are coming in that in South Africa it [Omicron] is replacing it [Delta] rather fast. So everything is possible," Gintsburg said.

According to the Gamaleya institute director, the effectiveness of the Russian Sputnik V vaccine against the Omicron strain will be tested within ten days.

Earlier this month, Gintsburg told Sputnik that the Gamaleya institute confirmed that the patients infected with Omicron who had arrived in Russia from South Africa had been vaccinated.

At the end of November, Gintsburg said that any decisions on replacing the existing vaccine will be made only after complete data on Omicron becomes available. If necessary, the development of a new vaccine will take no more than ten days and regulatory procedures will take anywhere between 45 days and two and a half months, Gintsburg specified.

Earlier in December, South African President Cyril Ramaphosa said that the Omicron coronavirus variant accounts for most of the new COVID-19 cases in the majority of South African provinces. The Omicron strain was first identified in South Africa in late November. The World Health Organization (WHO) designated the strain as a variant of concern due to its high transmissibility rate.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronDelta variant of coronavirusRussiaCoronavirus Vaccine

First Published: Dec 13 2021 | 11:32 AM IST

Next Story